SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

___________

FORM 8-K

___________

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): ~~April~~June 829, 2011

Exmovere Holdings, Inc.

(EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER)


NEVADA	000-52713	20-8024018
(State or other jurisdiction of incorporation or organization)	(Commission file no.)	(IRS Employee Identification No.)

1600 Tysons Boulevard

8th Floor

McLean, VA 22102

(Address of Principal Executive Offices)

(703) 245-8513

(Registrant’s Telephone Number, Including Area Code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

~~oWritten~~¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

~~oSoliciting~~¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

~~oPre~~¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

~~oPre~~¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~ITEM~~Item 53.0203 ~~(A)~~Material ~~AND~~Modification ~~(B)~~of ~~DEPARTURE~~Rights OFof ~~DIRECTORS~~Security ~~AND OFFICERS~~Holders

Exmovere Holdings, Inc. (the “Company”) ~~acted~~is onauthorized ~~April~~by 8,the ~~2011~~articles of incorporation to ~~remove~~issue Mr35,000,000 shares. The ~~Cheyenne~~Company ~~Crow~~has ~~from~~issued ~~his~~15,853,250 ~~roles~~of asthose ashares. The ~~director~~Company ~~and~~has ~~the~~been ~~Chief~~listed ~~Operating~~on ~~Officer~~the ~~(“COO”)~~First Quotation Board of the ~~Company~~Frankfurt Stock Exchange since January of 2011. The Company ~~reasonably~~strategy ~~believes~~involves ~~that~~the Mrresearch, development and marketing of its products. The ~~Cheyenne~~Company ~~Crow~~needs ~~abandoned~~to ~~his~~raise ~~duties~~capital asto ~~COO~~finance ~~and~~that astrategy. In ~~member~~furtherance of that goal, on June 29, 2011, the Board of Directors as of ~~January~~the ~~13,~~Company ~~2011. The~~voted ~~Company~~by ~~made~~written ~~the~~consent ~~removal~~to ofauthorize ~~Mr.~~the ~~Cheyenne~~issuance ~~Crow~~of asup ~~COO~~to ~~and~~3,000,000 aadditional ~~director~~shares of ~~the~~common ~~Company~~stock ~~retroactive~~which tomay ~~January~~be ~~13,~~converted ~~2011. The~~to ~~action~~Global ~~was~~Depository ~~taken~~Receipts into ~~accordance~~be ~~with~~sold ~~Nevada~~to ~~Statutes~~raise ~~and~~capital on the ~~Company’s~~Frankfurt ~~Bylaws~~Stock Exchange.

On June 30, 2011, the Company voted to divide its common stock into two classes of shares. The ~~foregoing~~Company ~~description~~will have 30,000,000 of Class A shares and 5,000,000 of Class B shares. The new class of shares, Class B shares, will have the ~~Board’s~~same ~~Action~~financial byrights ~~Written~~as ~~Consent~~Class isA ~~not~~shares. However, ~~intended~~the Class B shares will have superior voting rights. Each Class B share will have the voting power of seven Class A shares. On June 30, 2011, the Company voted to becancel ~~complete~~the December 15, 2008 agreement to pay royalties to BT2 International Inc. (“BT2”) and isExmocare, ~~qualified~~et inal ~~its~~and ~~entirety~~issue by1,600,000 Class B shares to David Bychkov and 400,000 Class B shares to BT2. That agreement required the ~~complete~~Company ~~text~~to place 5% of all gross revenues from the ~~Written~~sale ~~Consent~~of inproducts ~~Lieu~~and 10% of all gross revenues from monitoring and/or the sale of services, into a ~~Special~~royalty ~~Meeting~~pool (the “Royalty Pool”). 80% of the ~~Majority~~Royalty Pool was payable to Exmocare, et al and 20% of the Royalty Pool was payable to BT2. Exmocare, et al represents three limited liability companies owned or controlled by Company President and Chairman of the Board, OfDavid ~~Directors~~Bychkov. BT2 ~~attached~~is asa ancompany ~~exhibit~~in towhich ~~this~~director, ~~Current~~Joseph ~~Report~~Batty onowns ~~Form~~a ~~8-K~~controlling interest.

~~ITEM~~Prior 5to these resolutions, the Company had 15,853,250 in stock outstanding.02 After ~~(C)~~the ~~ELECTION~~effect OFof ~~DIRECTORS~~these resolutions, the Company may have up to 20,853,250 shares outstanding. Two million of those shares will be Class B shares that have the voting rights of fourteen million shares.

On April 11, 2011, in order to fill the vacancy on the Company board and pursuant to a resolution made in accordance with Section 7.6 of the Company’s bylaws, Dr. Jun Quion was elected as a director of the Company. Dr. Quion will serve as the Company’s director until the expiration of Mr. Crow’s term, when he will be up for election by the shareholders.

The foregoing description is qualified in its entirety by the complete text of the Board Resolution attached as an exhibit to this Current Report on Form 8-K.

Dr. Jun Quion is a licensed medical doctor who has worked as an independent contractor for the Company’s subsidiary, Clinica of Virginia, LLC. After Dr. Quion graduated from medical school, he was accepted in the competitive internal medicine residency program of the Baylor College of Medicine in Houston, Texas. At Baylor College of Medicine, he spent another year in research on Lipids and Atherosclerosis, under the preeminent Dr. Antonio Gotto. Dr. Quion pursued further training in cardiovascular medicine and interventional cardiology at the University of Connecticut. Dr. Quion currently practices at the Inova Heart and Vascular Institute in Fairfax, Virginia and is a valuable member of the Clinica supervisory and advisory team.

ITEM 9.01 FINANCIAL STATEMENT AND EXHIBITS.

(d) Exhibits.

10.1		Written Consent by Board of Directors
10.2		Resolution by the Board of Directors

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

	Exmovere Holdings, Inc.
Date: April 15, 2011	By:	/s/ David Bychkov
		David Bychkov Chief Executive Officer


	Exmovere Holdings, Inc.


	By:	/s/ David Bychkov
		David Bychkov Chief Executive Officer
		David Bychkov Chief Executive Officer

3Date: July 14, 2011

Filing Compare · Exmovere Holdings, Inc.